A comprehensive view of Moderna Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Moderna signs contract with Brazil's Ministry of Health to supply 12.5 million doses of its mRNA COVID-19 vaccine for the 2024 national vaccination campaign; vaccine delivery expected in Q2 2024

Boston Scientific's Farapulse PulseSelect Pulsed-Field Ablation system gains foothold in the US PFA system market; J&J remains top player in electrophysiology devices market with 54% market share

Moderna to report first quarter 2024 financial results on Thursday, May 2, 2024

Pfizer and BioNTech get temporary reprieve in patent dispute with Moderna, allowing more time for the Patent Trial and Appeal Board to review challenges; Pfizer and BioNTech’s COVID-19 vaccine to remain on the market despite lawsuit

Patent Application Titled 'Variant Strain-Based Coronavirus Vaccines' Published Online (USPTO 20240100151)

Ask us about our R&D/Patents market view

Trending Chart

Interactive chart with headline count